Elevated serum ferritin (a form of iron) levels are associated with coronary artery disease, malignancy, and poor stem cell transportation. It is also involved in conditions like neurodegenerative disorders, sideroblastic anemia, and hemophagocytic syndrome. Ferritin is an acute-phase reactant for the inflammatory response.
Ferritin, a major iron storage protein, is essential to iron homeostasis and is involved in a wide range of physiologic and pathologic processes. In clinical medicine, ferritin is predominantly utilized as a serum marker of total body iron stores. In cases of iron deficiency and overload, serum ferritin serves a critical role in both diagnosis and management. Elevated serum and tissue ferritin are linked to coronary artery disease, malignancy, and poor outcomes following stem cell transplantation. Ferritin is directly implicated in less common but potentially devastating human diseases including sideroblastic anemias, neurodegenerative disorders, and hemophagocytic syndrome. Additionally, recent research describes novel functions of ferritin independent of iron storage.